Soligenix updates medical advisory board for lymphoma treatment
PositiveFinancial Markets

Soligenix has made significant updates to its medical advisory board, enhancing its expertise in lymphoma treatment. This move is crucial as it reflects the company's commitment to advancing innovative therapies for patients battling this challenging disease. By bringing in experienced professionals, Soligenix aims to strengthen its research and development efforts, potentially leading to more effective treatment options and improved patient outcomes.
— Curated by the World Pulse Now AI Editorial System